3rd Quarter - Report

AKIN GUMP STRAUSS HAUER & FELD for BIOTECHNOLOGY INNOVATION ORGANIZATION

Firm
Client
Income
$80,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Issues related to the reauthorization of the FDA user fee agreements; issues related to FDA user fee agreements; issues related to prescription drug importation; issues related to the Inflation Reduction Act (HR 5376).

LobbyistCovered position, as disclosed
ANNA ABRAM —
MICHAEL BARNARD —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 5376 (117th)

Copyright/Patent/Trademark CPT

Issues related to intellectual property rights for COVID therapeutics.

LobbyistCovered position, as disclosed
BRIAN ARTHUR POMPER —

Contacted: SENATE

Trade (domestic/foreign) TRD

Issues related to intellectual property rights for COVID therapeutics.

LobbyistCovered position, as disclosed
BRIAN ARTHUR POMPER —

Contacted: SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.